Pericarditis Overview
Pericarditis is inflammation of the pericardium, a sac-like structure with two thin layers of tissue that surround the heart to hold it in place and help it work. A small amount of fluid keeps the layers separate so there’s less friction between them as the heart beats.
The cause of pericarditis is often unknown, though viral infections are a common reason. Pericarditis may occur after a respiratory or digestive system infection. Chronic and recurring pericarditis may be caused by autoimmune disorders such as lupus, scleroderma and rheumatoid arthritis.
Pericarditis Epidemiology Insights
The incidence of acute pericarditis is approximately 27.7 per 100,000 individuals annually. The recurrence of the disease is seen in almost 30% of patients after the first episode. The mortality rate of acute pericarditis is approximately 1.1% in developed countries.
It mostly affects men ages 20 to 50 years. Pericarditis is often the result of an infection such as Viral infection that causes a chest cold or pneumonia. Infections with bacteria (less common)
Click here to learn more about the Pericarditis Market Landscape
The Report Covers the Pericarditis Epidemiology Segmented by:
Total Pericarditis incident cases
Total Pericarditis prevalent cases
Total Pericarditis treatment cases
Total Pericarditis diagnostic cases
Pericarditis Market Outlook
Key Companies Working in the Pericarditis Market
Leo Pharmaceuticals
Cogent Biosciences
Novartis Pharmaceuticals
GT Biopharmaceuticals Inc
FSD Pharmaceuticals Inc
And many others
Pericarditis Therapies Covered and Analyzed in the Report:
Masitinib
Cromoglicate
TF002
Avapritinib
PA101
Learn more about the Key Companies and Emerging Therapies in the Pericarditis Market
Table of Contents
Key Insights
Pericarditis Introduction
Executive Summary of Pericarditis
Disease Background and Overview
Epidemiology and patient population
Pericarditis Emerging Therapies
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @ Pericarditis Market Outlook
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting/due-diligence-services